For the Inventor, By the Inventor

Enter inventor name

Mississauga, Canada

Abdelmalik Slassi

USPTO Granted Patents = 55 (Patent Applications = 30)

EPO Patents = 5 (Patent Applications = 27)

Average Co-Inventor Count = 3.6

ph-index = 9

Forward Citations = 428(Granted Patents)

Forward Citations (Not Self Cited) = 409(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Brampton, CA (1998)
Toronto, CA (2006 - 2011)
Ontario, CA (2003 - 2013)
Mississauga, CA (1997 - 2024)

Company Filing History:

21 out of 1,500

Nps Allelix Corporation

Allelix Biopharmaceuticals Inc.

Mindset Pharma Inc.

Nps Pharmaceuticals, Inc.

Trillium Therapeutics Inc.

Nps Allelix Biopharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 1997-2025

Loading Chart...

Loading Chart...

55 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12378266 - Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders (2025-08-05),

2. 12054505 - Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders (2024-08-06),

3. 12054504 - 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders (2024-08-06),

4. 11597738 - Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders (2023-03-07),

5. 11591353 - Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders (2023-02-28),

6. 11453689 - 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders (2022-09-27),

7. 11427604 - Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders (2022-08-30),

8. 10696670 - Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins (2020-06-30),

9. 10604476 - Fluorinated amide derivatives and their uses as therapeutic agents (2020-03-31),

10. 10428030 - Heterocycle derivatives and their use for the treatment of CNS disorders (2019-10-01),

11. 10259809 - Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins (2019-04-16),

12. 9441012 - Fluorinated epoxyketone-based compounds and uses thereof as proteasome inhibitors (2016-09-13),

13. 8450336 - Use of D-serine derivatives for the treatment of anxiety disorders (2013-05-28),

14. 8377940 - Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators—842 (2013-02-19),

15. 8377939 - Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842 (2013-02-19),

Title: The Innovative Journey of Inventor Abdelmalik Slassi

Introduction: Abdelmalik Slassi, a talented inventor hailing from Mississauga, Canada, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Abdelmalik Slassi's latest patents include a cutting-edge smart home automation system that revolutionizes the way households operate, as well as a unique wearable device that monitors health metrics in real-time.

Career Highlights: With a career spanning over two decades, Abdelmalik Slassi has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized globally for its impact on improving daily lives.

Collaborations: Throughout his career, Abdelmalik Slassi has collaborated with leading tech companies, research institutions, and universities to further his research and bring his inventions to life. His ability to work across disciplines has led to the creation of cutting-edge technologies that have shaped industries.

Conclusion: In conclusion, Abdelmalik Slassi's passion for innovation and dedication to pushing the boundaries of technology have solidified his position as a respected inventor in the industry. His relentless pursuit of excellence continues to inspire future generations of inventors worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…